Urinary Biomarkers of Urothelial Malignancies

Posted On 2021-04-27 14:36:56


Given our increasingly aging society, the number of patients with malignant urogenital diseases (e.g., prostate cancer, urothelial cancer, renal cell carcinoma) is increasing. Meanwhile, overdiagnosis and overtreatment are also problems, especially given the morbidities of many of the treatments available such as radical prostatectomy or radical cystectomy.

Editorial
Urinary biomarkers of urological malignancies
Kazutoshi Fujita

Review Article
A narrative review of urinary phospholipids: from biochemical aspect towards clinical application
Xin Li, Kenji Nakayama, Takayuki Goto, Shusuke Akamatsu, Takashi Kobayashi, Koji Shimizu, Osamu Ogawa, Takahiro Inoue

Narrative review of urinary glycan biomarkers in prostate cancer
Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hayato Yamamoto, Chikara Ohyama

Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review
Yujiro Hayashi, Kazutoshi Fujita

Urinary extracellular vesicles: a rising star in bladder cancer management
Fumihiko Urabe, Takahiro Kimura, Kagenori Ito, Yusuke Yamamoto, Shunsuke Tsuzuki, Jun Miki, Takahiro Ochiya, Shin Egawa

Extracellular vesicles in prostate cancer: a narrative review
Koji Hatano, Kazutoshi Fujita

UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives
Takashi Nagai, Taku Naiki, Toshiki Etani, Keitaro Iida, Yusuke Noda, Nobuhiko Shimizu, Teruki Isobe, Satoshi Nozaki, Takehiko Okamura, Ryosuke Ando, Noriyasu Kawai, Takahiro Yasui

Original Article
MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
Kyosuke Matsuzaki, Kazutoshi Fujita, Eisuke Tomiyama, Koji Hatano, Yujiro Hayashi, Cong Wang, Yu Ishizuya, Yoshiyuki Yamamoto, Takuji Hayashi, Taigo Kato, Kentaro Jingushi, Atsunari Kawashima, Takeshi Ujike, Akira Nagahara, Motohide Uemura, Kazutake Tsujikawa, Norio Nonomura

Disclosure:
The series “Urinary Biomarkers of Urothelial Malignancies” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Kazutoshi Fujita is serving as the unpaid Guest Editor for the series.